Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 18”

51 trials

Showing 20 of 51 results

Early research (Phase 1)Study completedNCT02031198
What this trial is testing

18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Axon Neuroscience SE 25
Not applicableStudy completedNCT01834716
What this trial is testing

Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study

Who this might be right for
Alzheimer's Disease Prevention
Mayo Clinic 16
Testing effectiveness (Phase 2)Study completedNCT02278367
What this trial is testing

Clinical Evaluation of Flortaucipir F 18

Who this might be right for
Alzheimer's DiseaseTraumatic Brain InjuryDepression
Avid Radiopharmaceuticals 179
Large-scale testing (Phase 3)Study completedNCT01565382
What this trial is testing

Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 40
Early research (Phase 1)Study completedNCT01564706
What this trial is testing

18F-AV-45 in Healthy Volunteers

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 9
Large-scale testing (Phase 3)Study completedNCT01265394
What this trial is testing

Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects

Who this might be right for
Healthy
GE Healthcare 218
Testing effectiveness (Phase 2)Study completedNCT02813070
What this trial is testing

Comparison of PET Amyloid Imaging in Japanese and Western Subjects

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseHealthy
GE Healthcare 70
Early research (Phase 1)Study completedNCT01565330
What this trial is testing

Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 20
Post-approval studies (Phase 4)Active Not RecruitingNCT01606488
What this trial is testing

Effects of Brain Beta-Amyloid on Postoperative Cognition

Who this might be right for
Postoperative Cognitive Dysfunction
University of California, San Francisco 66
Not applicableStudy completedNCT03279523
What this trial is testing

F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected

Who this might be right for
Alzheimer DiseaseHIV
Tammie L. S. Benzinger, MD, PhD 60
Large-scale testing (Phase 3)Study completedNCT03901092
What this trial is testing

A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 242
Testing effectiveness (Phase 2)Active Not RecruitingNCT05531656
What this trial is testing

Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

Who this might be right for
Early Alzheimer's Disease
Cognition Therapeutics 540
Large-scale testing (Phase 3)Study completedNCT00103649
What this trial is testing

18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Sanofi 1,306
Very early researchStudy completedNCT01565291
What this trial is testing

A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 32
Large-scale testing (Phase 3)Study completedNCT01447719
What this trial is testing

Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 110
Large-scale testing (Phase 3)WithdrawnNCT05124561
What this trial is testing

Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)

Who this might be right for
COVID-19
CanSino Biologics Inc.
Not applicableStudy completedNCT01565369
What this trial is testing

Evaluation of Physician Training Methods to Read Florbetapir-PET Scans

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 35
Not applicableStudy completedNCT04726527
What this trial is testing

Clinical Evaluation of Florbetapir in Primary Progressive Aphasia

Who this might be right for
Primary Progressive AphasiaAlzheimer DiseaseDementia
University of Chicago 48
Large-scale testing (Phase 3)Looking for participantsNCT06709014
What this trial is testing

Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

Who this might be right for
Early Alzheimers Disease
Annovis Bio Inc. 760
Not applicableStudy completedNCT01565356
What this trial is testing

Evaluation of PET Scan Timing Relative to AV-45 Injection Time

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 41
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation